Novel Targeted Therapies for T-Cell Malignancies.


Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Aug 2022
Historique:
received: 13 07 2022
accepted: 20 07 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

T-cell malignancies comprise a heterogeneous group of cancers resulting from the clonal expansion of T-cells at different developmental stages [...].

Identifiants

pubmed: 36010948
pii: cancers14163955
doi: 10.3390/cancers14163955
pmc: PMC9406054
pii:
doi:

Types de publication

Editorial

Langues

eng

Déclaration de conflit d'intérêts

The author declares no conflict of interest.

Références

Sci Transl Med. 2019 May 29;11(494):
pubmed: 31142678
J Clin Oncol. 2021 Oct 20;39(30):3340-3351
pubmed: 34324392
Haematologica. 2012 Sep;97(9):1405-13
pubmed: 22491738
Bone Marrow Transplant. 2017 Nov;52(11):1583-1584
pubmed: 28892087
J Exp Med. 2017 May 1;214(5):1371-1386
pubmed: 28424246
Blood Adv. 2021 Dec 14;5(23):5098-5106
pubmed: 34507350
Cell Chem Biol. 2020 Jun 18;27(6):678-697.e13
pubmed: 32386594
Pediatr Blood Cancer. 2020 Dec;67(12):e28688
pubmed: 32896942
J Hematol Oncol. 2020 Dec 31;13(1):176
pubmed: 33384022
Cancers (Basel). 2020 Aug 15;12(8):
pubmed: 32824175
Neoplasia. 2019 Jan;21(1):82-92
pubmed: 30529073
Genes Chromosomes Cancer. 2016 Jan;55(1):82-94
pubmed: 26493028
Blood. 2019 Oct 24;134(17):1395-1405
pubmed: 31471376
Oncogene. 2016 Jul 28;35(30):3887-96
pubmed: 26616857
J Clin Invest. 2017 Sep 1;127(9):3462-3471
pubmed: 28805662
J Clin Oncol. 2012 Feb 20;30(6):631-6
pubmed: 22271479
J Hematol Oncol. 2016 Mar 10;9:22
pubmed: 26965915
Br J Haematol. 2019 Jul;186(2):274-285
pubmed: 30957229
Cancer Cell. 2010 Sep 14;18(3):268-81
pubmed: 20832754
N Engl J Med. 2018 May 17;378(20):1947-1948
pubmed: 29768155
Nature. 2017 Dec 7;552(7683):121-125
pubmed: 29143824
Blood. 2021 Jun 24;137(25):3495-3506
pubmed: 33598678
Blood. 2017 Apr 27;129(17):2437-2442
pubmed: 28188133
Clin Cancer Res. 2019 Dec 15;25(24):7275-7280
pubmed: 31366601
Nat Med. 2014 Oct;20(10):1130-7
pubmed: 25194570
Nat Genet. 2015 Dec;47(12):1465-70
pubmed: 26551667
Curr Treat Options Oncol. 2020 May 28;21(7):57
pubmed: 32468488
Leukemia. 2014 Feb;28(2):278-88
pubmed: 23774673
Blood Adv. 2020 May 26;4(10):2213-2226
pubmed: 32437546
Cancer Sci. 2017 Sep;108(9):1719-1725
pubmed: 28627735
Blood Adv. 2020 Oct 13;4(19):4640-4647
pubmed: 33002132
Blood. 2018 Nov 22;132(21):2305-2309
pubmed: 30279227
Am J Clin Dermatol. 2019 Feb;20(1):115-122
pubmed: 30430444
Leukemia. 2018 Nov;32(11):2307-2315
pubmed: 30315238
J Invest Dermatol. 2021 Mar;141(3):484-495
pubmed: 33162051
Blood. 2009 Jul 16;114(3):647-50
pubmed: 19458356
Blood. 2021 Jul 1;137(26):3595-3603
pubmed: 33684925
Am J Hematol. 2017 Jul;92(7):706-715
pubmed: 28516671
J Clin Oncol. 2015 Aug 10;33(23):2492-9
pubmed: 26101246

Auteurs

Melania Tesio (M)

UR LIB "Lymphoma Immune Biology"-INSERM U111, Centre International de Recherche en Infectiologie (CIRI), 69007 Lyon, France.

Classifications MeSH